DermaFlow

Detecting non-invasively earliest signs of acute & chronic health status; products transitioning hospital, out-patient & home/remote.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Plainsboro, NJ, USA
  • Currency USD
  • Founded November 2011
  • Employees 7
  • Incorporation Type LLC
  • Website dermaflow.com

Company Summary

Microcirculation is a well known & researched parameter, but a device having optimal attributes for routine assessment has not emerged to date. First signs of change in acute and chronic health status occur in peripheral blood flow. Mission to provide non-invasive products allowing cost-effective & routine assessment of capillary blood flow changes, i.e. microcirculation. Targeting vital care,hemodynamics, wound healing and chronic disease.

Team

  • Dr. Irene Jaffe
    Chief Executive Officer

  • Ilya Skoletsky
    Chief Technology Officer

  • Dr. Daniel Weiss
    Chief Medical Officer

  • James Kleinburd
    Chairman of the Board

  • Bruce Anderson
    SVP and Manager of US Operations

Advisors

  • David Gitlin, Esq., GreenbergTraurig, Philadephia, PA
    Lawyer
    Unconfirmed
    David Evans, Cherry Hill, NJ
    Accountant
    Unconfirmed

Previous Investors

  • Dotan Technologies Ltd.
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free